Loss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity

References

• Ridley AJ. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends in Cell Biology 2006; 16:522-9.
   PubMed Web of Science ®Google Scholar
• Hall A. Rho family GTPases. Biochem Soc Trans 2012; 40:1378-82.
   PubMed Web of Science ®Google Scholar
• Etienne-Manneville S. Cdc42 - the centre of polarity. Journal of Cell Science 2004; 117:1291-300.
   PubMed Web of Science ®Google Scholar
• Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 2002; 4:513-8.
   PubMed Web of Science ®Google Scholar
• Liu BP, Burridge K. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins. Mol Cell Biol 2000; 20:7160-9.
   PubMed Web of Science ®Google Scholar
• Etienne-Manneville S, Hall A. Cdc42 regulates GSK-3[beta] and adenomatous polyposis coli to control cell polarity. Nature 2003; 421:753-6.
   PubMed Web of Science ®Google Scholar
• Michaelson D, Silletti J, Murphy G, D’Eustachio P, Rush M, Philips MR. Differential Localization of Rho Gtpases in Live Cells: Regulation by Hypervariable Regions and Rhogdi Binding. The Journal of Cell Biology 2001; 152:111-26.
   PubMed Web of Science ®Google Scholar
• Erickson JW, Zhang C-j, Kahn RA, Evans T, Cerione RA. Mammalian Cdc42 Is a Brefeldin A-sensitive Component of the Golgi Apparatus. Journal of Biological Chemistry 1996; 271:26850-4.
   PubMed Web of Science ®Google Scholar
• Baschieri F, Confalonieri S, Bertalot G, Di Fiore PP, Dietmaier W, Leist M, et al. Spatial control of Cdc42 signalling by a GM130–RasGRF complex regulates polarity and tumorigenesis. Nat Commun 2014; 5.
   Google Scholar
• Farhan H, Rabouille C. Signalling to and from the secretory pathway. Journal of Cell Science 2011; 124:171-80.
   PubMed Web of Science ®Google Scholar
• Yang G, Cynader MS. Regulation of protein trafficking: JNK3 at the Golgi complex. Cell Cycle 2014; 13:5-6.
   PubMed Web of Science ®Google Scholar
• Millarte V, Farhan H. The Golgi in cell migration: regulation by signal transduction and its implications for cancer cell metastasis. ScientificWorldJournal 2012; 2012:498278.
   PubMed Web of Science ®Google Scholar
• Baschieri F, Farhan H. Crosstalk of small GTPases at the Golgi apparatus. Small GTPases 2012; 3:80-90.
   PubMedGoogle Scholar
• McCaffrey Luke M, Montalbano J, Mihai C, Macara Ian G. Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis. Cancer Cell 2012; 22:601-14.
   PubMed Web of Science ®Google Scholar
• Xue B, Krishnamurthy K, Allred DC, Muthuswamy SK. Loss of Par3 promotes breast cancer metastasis by compromising cell–cell cohesion. Nat Cell Biol 2013; 15:189-200.
   PubMed Web of Science ®Google Scholar
• Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, et al. Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma. Cell 2008; 135:865-78.
   PubMed Web of Science ®Google Scholar
• Weller SG, Capitani M, Cao H, Micaroni M, Luini A, Sallese M, et al. Src kinase regulates the integrity and function of the Golgi apparatus via activation of dynamin 2. Proc Natl Acad Sci U S A 2010; 107:5863-8.
   PubMed Web of Science ®Google Scholar
• Bard F, Mazelin L, Péchoux-Longin C, Malhotra V, Jurdic P. Src Regulates Golgi Structure and KDEL Receptor-dependent Retrograde Transport to the Endoplasmic Reticulum. Journal of Biological Chemistry 2003; 278:46601-6.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74.
   PubMed Web of Science ®Google Scholar
• Qiao X, Roth I, Feraille E, Hasler U. Different effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion. Cell Cycle 2014; 13:3059-75.
   PubMed Web of Science ®Google Scholar
• Bilder D. Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes & Development 2004; 18:1909-25.
   PubMed Web of Science ®Google Scholar
• Gligorijevic B, Bergman A, Condeelis J. Multiparametric Classification Links Tumor Microenvironments with Tumor Cell Phenotype. PLoS Biol 2014; 12:e1001995.
   PubMed Web of Science ®Google Scholar
• Patsialou A, Bravo-Cordero JJ, Wang Y, Entenberg D, Liu H, Clarke M, et al. Intravital multiphoton imaging reveals multicellular streaming as a crucial component of in vivo cell migration in human breast tumors. Intravital 2013; 2:e25294.
   PubMedGoogle Scholar
• Dang I, Gorelik R, Sousa-Blin C, Derivery E, Guerin C, Linkner J, et al. Inhibitory signalling to the Arp2/3 complex steers cell migration. Nature 2013; 503:281-4.
   PubMed Web of Science ®Google Scholar
• Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer cell 2006; 10:515-27.
   PubMed Web of Science ®Google Scholar
• Ma B, van Blitterswijk CA, Karperien M. A Wnt/β-catenin negative feedback loop inhibits interleukin-1–induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis & Rheumatism 2012; 64:2589-600.
   PubMed Web of Science ®Google Scholar
• Riaz M, Elstrodt F, Hollestelle A, Dehghan A, Klijn JG, Schutte M. Low-risk susceptibility alleles in 40 human breast cancer cell lines. BMC Cancer 2009; 9:236.
   PubMed Web of Science ®Google Scholar
• Kao J, Salari K, Bocanegra M, Choi Y-L, Girard L, Gandhi J, et al. Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery. PLoS ONE 2009; 4:e6146.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Warne PH, Downward J. PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs. Oncogene 2011; 30:3222-33.
   PubMed Web of Science ®Google Scholar
• Krypuy M, Ahmed A, Etemadmoghadam D, Hyland S, Australian Ovarian Cancer Study G, deFazio A, et al. High resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer 2007; 7:168.
   PubMed Web of Science ®Google Scholar
• Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. The Journal of Clinical Investigation 2011; 121:2750-67.
   PubMed Web of Science ®Google Scholar
• Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14:518-27.
   PubMed Web of Science ®Google Scholar
• Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012; 486:346-52.
   PubMed Web of Science ®Google Scholar